Similarly, we found that CpGI hypermethylation may occur in the MAOB promoter, and 5-Aza treatment increased MAOB expression in ccRCC cells, suggesting that hypomethylating agents could serve as potential MAOB inducers in ccRCC. This evidence concerns the gene MAOB and nonpapillary renal cell carcinoma.